What researchers published on Zsírmáj (MASLD/MASH)
40 075 papers, newest first.
Showing 180 of 40 075
All-cause mortality across cryptogenic steatotic liver disease and MASLD phenotypes: an NHANES III cohort study.Endocrine
ÁttekintésBiomarkers to assess early signs of fibro-inflammatory disease modification following short-term therapeutic intervention in people living with MASLD/MASH: A systematic scoping review.PloS one
ÁttekintésStage-predominant epigenetic framework across the MASLD spectrum: global evidence and the Saudi Arabian context.Epigenomics
How low can you go? Is lower-dose vitamin E effective and safe for MASH?Hepatology (Baltimore, Md.)
Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes.International journal of endocrinology
Finding the hidden epidemic: screening for metabolic dysfunction-associated steatotic liver disease.Proceedings (Baylor University. Medical Center)
Two drugs, one liver: A real-world test of GLP-1 RA and SGLT-2i combination therapy in MASLD.Hepatology (Baltimore, Md.)
ÁttekintésHepatic metabolic plasticity: From physiological adaptation to energy overload-associated pathological progression and therapeutic targeting.Journal of physiology and biochemistry
Integrative transcriptomic and single-nucleus analyses identify microbiota-metabolite-associated immune signatures of fibrosis severity in MASLD.PloS one
Proteome-Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity-Related MASLD.Obesity (Silver Spring, Md.)
Cold-Shock-Primed Lactobacillus rhamnosus GG Extracellular Vesicles Restore Liver-Gut Axis Homeostasis Through Bile Acid Metabolic Reprogramming in MASLD.Journal of extracellular vesicles
Analysis of drug development risks for metabolic dysfunction-associated steatotic liver disease from a sustainable accounting perspective.Cost effectiveness and resource allocation : C/E
The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of observational studies.Sage open chronic disease
ÁttekintésUltrasound quantification of liver fat in MASLD.European radiology
Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model.In vitro models
Carbon Dots Derived from Carbonized Citri Reticulatae Pericarpium (Chenpi) Alleviate Metabolic Dysfunction-Associated Steatohepatitis.Molecules (Basel, Switzerland)
Reply to Khan and Shoro: Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers.Hepatology forum
Randomizált vizsgálatEffects of Whole "Navelina" Orange Consumption on Glucose Homeostasis and Fructosamine Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Controlled Trial.Nutrients
ÁttekintésThe role and mechanisms of the vascular microenvironment in metabolic dysfunction- associated fatty liver disease.Frontiers in endocrinology
Early Metabolic and Cardiovascular Alterations in Adolescents with MASLD or Simple Obesity.Nutrients
Integrated Cardiovascular-Kidney-Metabolic Disease Burden in Mexico: Trends from 2000 to 2023 and Projections to 2050.Annals of global health
Growth Hormone Reduces Liver Tumor Development in a MASLD-Related HCC Murine Model.International journal of molecular sciences
Renal Multiparametric MRI for Early Detection and Longitudinal Monitoring of Metabolic Dysfunction Associated Steatotic Liver Disease Associated Kidney Injury: Histopathologic Validation and Multi-Omics Profiling.Journal of magnetic resonance imaging : JMRI
Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment.Journal of clinical medicine
ÁttekintésNavigating MASLD heterogeneity: from metabolic risk to precision stratification.Frontiers in medicine
Gut microbiota dysbiosis and altered short-chain fatty acid biosynthetic pathways in Chinese children with obesity and nonalcoholic fatty liver disease.Frontiers in endocrinology
MetaanalízisSilymarin-Based Therapies in Chronic Liver Disease: A Systematic Review of Biochemical, Cardiometabolic, Steatosis, and Fibrosis-Related Outcomes.Nutrients
Network toxicology, molecular docking and in vitro validation reveal the molecular mechanisms of bisphenol A-induced MASLD.Frontiers in pharmacology
Circadian Rhythm-Related Characteristics and Adiposity in Relation to CAP-Defined Hepatic Steatosis Among Shift and Non-Shift Workers: A Pilot Study.Nutrients
Short- and Medium-Chain Fatty Acid Profiles in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study.Nutrients
Chronic Consumption of Ghee (Clarified Butter) and Coconut Oil, but Not Palmolein, Induces Microvesicular Steatosis, Insulin Resistance, and Inflammation in Mice Fed a High-Fat Diet.Nutrients
Association Between Free Triiodothyronine and Metabolic Dysfunction-Associated Steatotic Liver Disease in Euthyroid Population: Evidence from NHANES 2007-2012.Healthcare (Basel, Switzerland)
Transcriptomic Profiling Identifies Hub Transcription Factors Associated with the Protective Effects of Licochalcone A Against HFD-Induced MASLD.Nutrients
Szisztematikus áttekintésUltra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights.Nutrients
ÁttekintésNutritional Impairment and Muscle Health in MASLD: The Potential Role of Eating Behaviors.Journal of clinical medicine
Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats.European radiology experimental
Altered Hepatic Hydrogen Sulfide-Related Homeostasis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Changes Following Sleeve Gastrectomy.Journal of clinical medicine
ÁttekintésStatins and the Lifetime Outcomes of MASLD: From Evidence Asymmetry to Outcome Convergence.International journal of molecular sciences
Bacillus megaterium 1259 Limits Hepatic Lipid Accumulation in Mice with Established Diet-Induced Obesity: Paired Hepatic Transcriptomic and Metabolomic Profiling.Nutrients
MetaanalízisLarge-Scale Transcriptomic Meta-Analysis of Mouse Liver Responses to High-Fat Diet Identifies a Reproducible Core and Duration-Associated Variation.International journal of molecular sciences
ÁttekintésTrained Immunity and Persistent Myeloid Responsiveness in MASH.Cells
ÁttekintésMitochondrial Fatty Acid Oxidation Dysregulation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Roles and Emerging Diagnostic and Therapeutic Advances.Pharmacological research
MRI-Derived Muscle Composition and Visceral Adiposity in Relation to Mortality and Vascular Outcomes in MASLD.Diagnostics (Basel, Switzerland)
Response to "Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers".Hepatology forum
Integrated chemical profiling and lipidomics reveal that Mailuoning oral liquid alleviates diet-induced MASLD via PPARα-mediated lipid homeostasis and COX-2 inhibition, with identification of potential active constituents.Frontiers in pharmacology
Low-intensity pulsed ultrasound ameliorates diet-induced MASLD with hepatic lipid metabolic remodeling.Biochimica et biophysica acta. Molecular basis of disease
Early Sugar Exposure and the Lifelong Prevention of MASLD.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study.Medicine
Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
Metabolic Dysfunction-Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing-Risk Cohort Study.Geriatrics & gerontology international
Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study.Frontiers in medicine
Direct Remnant Lipoprotein Profiling Reveals Subfraction-Level Associations with Biopsy-Proven MASH in Severe Obesity.Journal of lipid research
Elevated malonic acid and 15d-PGJ2 in MASLD rats with diabetes triggered pathological cardiac remodeling through impairment of mitochondrial health and cellular metabolism.Journal of molecular and cellular cardiology
Targeting FSP1 to Suppress PI3K/AKT Signaling: Enarodustat Ameliorates MASH via Ferroptosis Inhibition and Lipid Metabolism Regulation.European journal of pharmacology
Szisztematikus áttekintésKetogenic Diet Effects on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver
ÁttekintésNutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD).Food science and biotechnology
ÁttekintésNatural Bioactive Compounds Targeting Lipid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease.Phytotherapy research : PTR
Reply to Comments to Diagnostic Value and Influencing Factors of Ultrasound-Derived Fat Fraction for Quantifying MASLD in Children.Liver international : official journal of the International Association for the Study of the Liver
ÁttekintésCompositional diversity and dietary implications of cereal and legume crops as functional resources for non-alcoholic fatty liver disease prevention: a review.Food science and biotechnology
Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.Frontiers in endocrinology
Total-Body 18F-FAPI PET/CT for Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ÁttekintésTherapeutic opportunities of fecal microbiota transplantation in the treatment of non-alcoholic fatty liver disease.Frontiers in cellular and infection microbiology
ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD.EMBO molecular medicine
Áttekintés[Research progress on male reproductive function impairment caused by metabolic dysfunction-associated steatotic liver disease].Zhonghua nan ke xue = National journal of andrology
Correction: Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait.Frontiers in endocrinology
Investigating the regulatory potential of interval training and IPA supplementation on modulating the hepatic gluconeogenesis pathway in rats with non-alcoholic fatty liver disease.BMC gastroenterology
Cognitive impairment in metabolic dysfunction-associated steatotic liver disease ‒ Clinical evidence, liver-brain mechanisms and research priorities.Revista espanola de enfermedades digestivas
ÁttekintésFructose-related metabolic stress in MASLD: integrating intestinal substrate partitioning, hepatic phosphorus metabolite dynamics, and the inflammatory-fibrotic interface.Frontiers in medicine
A Minimally Invasive Diagnostic Platform Compatible with Tissue and Serum Analysis for Early Detection of Non-Alcoholic Fatty Liver Disease.Analytical chemistry
Joint effects of phenotypic age acceleration and novel insulin resistance indicators on mortality in adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.Cardiovascular diabetology
Metabolic dysfunction-associated steatotic liver disease: Delphi consensus with specialists on comprehensive approach, public health policies, and primary care physicians' perspectives.Gaceta medica de Mexico
Machine learning-based prediction of non-alcoholic fatty liver disease in Chinese perimenopausal women: a retrospective observational study.BMJ open
Changing etiological spectrum and the rise of metabolic risk in liver cancer burden in China (1990-2021) with projections to 2036: a decomposition analysis based on the GBD 2021 study.BMC cancer
An Enzyme-Triggered Self-Immobilizing Dual-Modal Probe for Precision Imaging and Sustained Gas Therapy of Early-Stage MASH.Analytical chemistry
ÁttekintésPredicting response to GLP-1-based therapy in MASLD/MASH: an evidence-tiered, endpoint-specific framework built on host genotype and gut microbial features.Frontiers in endocrinology
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study.The lancet. Gastroenterology & hepatology
Associations of cumulative exposure and dynamic trajectories of the normalized creatinine-to-cystatin C ratio with incident cardiovascular disease in middle-aged and older Chinese adults with metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study.BMC cardiovascular disorders
Biological sex modifies the link between nutrient intake and metabolic dysfunction-associated steatotic liver disease: intrinsic oxidative vulnerability in females.Journal of the Endocrine Society
GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis.Internal medicine (Tokyo, Japan)
Szisztematikus áttekintésPolyamine Dysregulation in Metabolic Dysfunction-associated Steatotic Liver Disease: a Systematic Review of Human Observational Evidence.Current obesity reports
Claims-defined hepatic steatosis compatible with MASLD and reproductive outcomes after the first observed embryo transfer: a Korean nationwide cohort study.BMC gastroenterology
Decoding Mitochondrial CircRNA Dynamics with In Situ Super-Resolution Bioimaging and Quantification via a Ratiometric DNA Tetrahedral Amplifier.Analytical chemistry
Elevated Risk of Bladder Cancer Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease in Elderly Korean Men: A Nationwide Cohort Study.Journal of Korean medical science
ÁttekintésHepatocyte-derived lipid droplets in MASH: macrophage sensing and inflammation.Frontiers in immunology
Conventional Preoperative Prediction of MASLD-Compatible Histologic Abnormality, Fibrosis, and Higher-Grade Steatohepatitis, and Exploratory Machine-Learning Classification of MASH Severity in Patients Undergoing Roux-en-Y Gastric Bypass.Obesity surgery
Longitudinal Changes in Physical Performance with Metabolic Dysfunction-Associated Steatotic Liver Disease and Coronary Artery Disease.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Unresolved questions for nutrient-stimulated hormonal multi-agonists in MASH; more receptors, better livers?: Editorial on "Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders".Clinical and molecular hepatology
ÁttekintésDietary interventions in metabolic dysfunction-associated steatotic liver disease: current evidence, research priorities, and clinical translation.Clinical and experimental hepatology
Liquiritigenin Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK-Mediated Dual Activation of PPARα/PPARγ.Food science & nutrition
Elevated circulating activin A is associated with disease severity in advanced steatotic liver disease (SLD).BMC gastroenterology
Neuro-immune and metabolic disorders in association with depression, anxiety, and chronic fatigue-fibromyalgia symptoms due to nonalcoholic fatty liver disease.CNS spectrums
EsetismertetésGlycogenic Hepatopathy Mimicking Overlapping with Metabolic Dysfunction-Associated Steatotic Liver Disease in Newly Diagnosed Type 2 Diabetes: A Case Report.SAGE open medical case reports
Comment on "Effect of High Dose N-Acetyl Cysteine Supplementation on Markers of Oxidative Stress and Insulin Resistance in Non-Diabetic Patients With Metabolic Dysfunction Associated Steatotic Liver Disease: A Randomized Controlled Trial".Journal of gastroenterology and hepatology
3β-trans-CLD alleviates metabolic dysfunction-associated steatotic liver disease (MASLD) via modulating the IDO1/Nrf2/SREBP1/SCD1 axis in vitro.Fitoterapia
ÁttekintésEffects of Bacterial-Derived Extracellular Vesicles in Rodent Models of Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease and Insulin Resistance/type 2 Diabetes. A Systematic Review.Probiotics and antimicrobial proteins
Propolis Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Phytotherapy research : PTR
DTC1225, a novel benzothiazole-based compound, ameliorates MASLD by restoring metabolic-redox homeostasis and promoting hepatic lipid remodeling.Metabolism: clinical and experimental
Numerical reproducibility and threshold interpretation in MASLD risk stratification.Clinical and molecular hepatology
Letter to the Editor on "Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations".Clinical and molecular hepatology
Efinopegdutide: a step towards precision in MASH therapy?Lancet (London, England)
What Does Normal BMI Hide in MASLD? Body Composition and Cause-Specific Mortality After Reclassification: Authors' reply.Clinical and molecular hepatology
GLP-1/Glucagon Receptor Dual Agonists for Metabolic Dysfunction-Associated Steatohepatitis and Steatotic Liver Disease (MASH/MASLD): A Systematic Review and Meta-Analysis.Digestive diseases (Basel, Switzerland)
TMEM189/PEDS1 deficiency aggravates MASH progression by promoting FASN-mediated macrophage activation.Cell death & disease
Clarifying local price mapping, response thresholds, and re-treatment structure in MASLD cost-effectiveness modeling.Clinical and molecular hepatology
Saroglitazar Facilitates Insulin De-escalation and Improves Metabolic Parameters in Pioglitazone-Ineligible Non-metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Type 2 Diabetes: Real-World Evidence From India.Cureus
Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis".Clinical and molecular hepatology
A Liver-Targeted CIDEB siRNA in Adults with MASLD.The New England journal of medicine
Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD.Clinical and molecular hepatology
Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2-3 fibrosis: a phase 2b, randomised, placebo-controlled study.Lancet (London, England)
Sex-Specific Risk Thresholds of Binge-Drinking Frequency for Advanced Fibrosis in MetALD and ALD: Analysis of the NHANES Cohort.Alcohol, clinical & experimental research
Correspondence on reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD".Clinical and molecular hepatology
Beyond BMI in MASLD: Rethinking Lean Phenotypes and Metabolic Risk Stratification: Authors' reply.Clinical and molecular hepatology
Reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD".Clinical and molecular hepatology
Beyond BMI in MASLD: Rethinking Lean Phenotypes and Metabolic Risk Stratification: Letter to the Editor on "Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations".Clinical and molecular hepatology
Reply to correspondence on "Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study".Clinical and molecular hepatology
Correspondence on an Editorial regarding "DNMT1 Conducts the Epigenetic Symphony Shaping MASLD Progression".Clinical and molecular hepatology
Health-care burden of metabolic dysfunction-associated steatotic liver disease in European tertiary-care outpatient clinics (CONSTANS): a prospective multicentre cohort study.The Lancet regional health. Europe
Author Reply to Letter to the Editor Regarding ''Beyond Awareness: A Qualitative Assessment of Barriers and Facilitators to Implementing Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) Care Pathways in Primary Care''.Gastro hep advances
PreprintHepatocyte UBE4A protects against MASLD and MASH by maintaining ER homeostasis via UBXN4 interaction.bioRxiv : the preprint server for biology
Mapping the NASH-CHECK to the EQ-5D-5L in a MASLD population in seven European countries.Health and quality of life outcomes
Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.Journal of gastrointestinal oncology
Native T1 mapping radiomics for assessing FIB-4-associated fibrosis risk in metabolic dysfunction-associated steatotic liver disease.Quantitative imaging in medicine and surgery
Superiority of magnetic resonance elastography and proton density fat fraction: an umbrella meta-analysis of non-invasive imaging for hepatic steatosis and fibrosis in metabolic dysfunction-associated steatotic liver disease and chronic hepatitis B.Quantitative imaging in medicine and surgery
ÁttekintésWill GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective.Frontiers in endocrinology
Identification of Neuroinflammation-Related Diagnostic Biomarkers in Metabolic Dysfunction-Associated Steatohepatitis: An Integrated Bioinformatics and Machine Learning Approach.Gastroenterology research and practice
Corrigendum to "Total extract of Folium Rhododendri Daurici alleviate MASLD by regulating PPAR and TNF signaling pathways" [J. Ethnopharmacol. 358, (2026), 120955].Journal of ethnopharmacology
Exposure to emerging and legacy PFAS and risks of metabolic dysfunction-associated steatotic liver disease and liver fibrosis in adults living near a semiconductor science park.Journal of hazardous materials
Metabolic syndrome and liver fibrosis in nondiabetic MASLD: A cross-sectional double machine learning study.Medicine
ÁttekintésAdipose tissue dysfunction and the liver: reframing MASH as the hepatic expression of systemic metabolic dysfunction.Frontiers in endocrinology
ÁttekintésMetabolic Dysfunction-Associated Steatotic Liver Disease and Sudden Cardiac Death: Epidemiology, Mechanisms, Risk Stratification, and Prevention.Heart rhythm
ÁttekintésFrom periodontal inflammation to hepatic immune remodeling: emerging concepts of myeloid reprogramming in stage-dependent MASLD.Frontiers in immunology
Mevalonate pathway regulates double-negative regulatory T cell stability in metabolic dysfunction-associated steatotic liver disease.Science advances
Thyroid-stimulating hormone-body mass index profile and mortality in metabolic dysfunction-associated steatotic liver disease.iLIVER
Lean metabolic dysfunction-associated steatotic liver disease.Current opinion in endocrinology, diabetes, and obesity
Developing and Externally Validating Explainable Machine Learning for Elastography-Defined Steatotic Liver Disease.Journal of visualized experiments : JoVE
SGLT2 inhibitor and fibrosis progression in MASLD: Correspondence to letter to the editor on "Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis".Clinical and molecular hepatology
Megfigyeléses vizsgálatFasting glucose-to-HDL cholesterol ratio and risk of MASLD in nonobese Chinese adults: A retrospective cohort study.Medicine
Association of Vascular Endothelial Growth Factor A +936 C/T Polymorphism With Non-Alcoholic Fatty Liver Disease in a Bangladeshi Population: A Case-Control Study.Health science reports
Trichrome-based deep learning for quantitative assessment of steatosis, hepatocellular ballooning, and fibrosis in metabolic dysfunction-associated steatohepatitis.Virchows Archiv : an international journal of pathology
Association of Triglyceride-to-HDL Cholesterol ratio with Body Mass Index in Nepalese Adults with Non-Alcoholic Fatty Liver Disease.Kathmandu University medical journal (KUMJ)
ÁttekintésThe Integrative Mechanism of Xiaoyaosan Through Liver-Brain Crosstalk in the Treatment of Depression Combined with MASLD.Drug design, development and therapy
Sex differences in the prevalence of metabolic dysfunction-associated steatotic liver disease in hospitalized patients: a single-center cross-sectional study.Frontiers in endocrinology
Correspondence to letter to the editor on "Evaluating treatment response thresholds for cost-effective treatment in metabolic dysfunction-associated steatotic liver disease".Clinical and molecular hepatology
Gudan Wan attenuates metabolic dysfunction-associated steatohepatitis by modulating autophagy and the Bcl-2/Caspase-3/Caspase-8 apoptotic axis.Frontiers in cell and developmental biology
Frequency and significance of rare LIPA variants associated with lysosomal acid lipase deficiency in metabolic dysfunction-associated steatotic liver disease: Results from the Nonalcoholic Steatohepatitis Clinical Research Network.Journal of pediatric gastroenterology and nutrition
Engineered Chiral Probiotics Ameliorate MASH via Gut-Liver Axis.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Relationship between triglyceride-high-density lipoprotein cholesterol-glucose-body index and nonalcoholic fatty liver disease in Chinese middle-aged and older adults: a secondary analysis of a cross-sectional cohort.BMC endocrine disorders
ÁttekintésMetabolic dysfunction-associated steatotic liver disease: Pathogenesis, complications and pharmacological treatment.EXCLI journal
Construction of a NAFLD identification model in Xizang population and exploration of risk factors related to liver fibrosis.BMC gastroenterology
MASLD clusters in multi-ethnic populations: similar subtypes with varying fibrosis outcomes.BMC gastroenterology
Lean MAFLD as an independent risk factor for carotid plaque: The value of FIB-4 index in subgroup analysis.PloS one
Annualized fibrosis dynamics in metabolic dysfunction-associated steatotic liver disease: a paired-biopsy cohort.Journal of gastroenterology
TUDCA was identified as a potential therapeutic drug for nonalcoholic steatohepatitis complicated with hypercholesterolemia targeting ADRA2C by integrated bioinformatics and experimental verification.Biology direct
Association between the red blood cell distribution width to albumin ratio and cardiovascular outcomes in MASLD patients: a national cohort study integrating machine learning.BMC cardiovascular disorders
ÁttekintésNoninvasive Diagnosis of Hepatocellular Carcinoma Outside Guideline-Defined High-Risk Populations: Evolving Perspectives in the Era of MASLD.Korean journal of radiology
Patient Awareness and Disease Burden in MASLD: A Large-Scale Survey.JHEP reports : innovation in hepatology
Comparing attenuation parameter and liver stiffness measurement using Hepatus and Fibroscan for the evaluation of steatosis and fibrosis in patients with chronic liver disease: A prospective study.PloS one
ÁttekintésSelenium Nanoparticles in Atherosclerosis and Non-Alcoholic Fatty Liver Disease: A Comprehensive Review of Therapeutic Mechanisms, Targeted Delivery, and Translational Prospects.International journal of nanomedicine
IL-34 ameliorates MASLD by regulating the synthesis of gut microbiota-derived metabolites LPS and IMP.Cellular and molecular life sciences : CMLS
Sodium Butyrate Ameliorates Hepatic Steatosis and Insulin Resistance in MASLD Models With Concurrent Alterations in AMPK and PI3K/AKT Signaling.Frontiers in bioscience (Landmark edition)
UHPLC-Q-TOF-MS Identification of Intestinal Absorbable Components of Yindan Pinggan Capsule and Exploration of Its Anti-NAFLD Mechanism Based on NF-κB Signaling Regulation.Biomedical chromatography : BMC
GAN diet-induced MASLD is associated with compartment-dependent transcriptional alterations in orthotopic hepatocellular carcinoma and adjacent liver.Biochemical and biophysical research communications
Jujuboside A ameliorates T2DM-associated MASH: Suppression of YY1/FAS axis-mediated hepatic de novo fatty acid biosynthesis.The Journal of nutritional biochemistry
Boldine ameliorates metabolic dysfunction-associated steatotic liver disease via Nrf2-mediated mitochondrial and ferroptotic regulation.Archives of biochemistry and biophysics
Upregulation of serum expression of miR-217 in non alcoholic fatty liver disease.Molecular biology research communications
Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort.Journal of Korean medical science
ÁttekintésMetabolic Dysfunction-Associated Steatotic Liver Disease and Extrahepatic Cancers.British journal of hospital medicine (London, England : 2005)
Estimated glucose disposal rate outperforms other insulin resistance surrogate indices in predicting cardiometabolic disease and major adverse cardiovascular events in metabolic dysfunction-associated steatotic liver disease: insights from UK Biobank.Cardiovascular diabetology
ÁttekintésGut microbiota and treatment response heterogeneity across pharmacological therapies for MASH.Frontiers in pharmacology
ÁttekintésMolecular smugglers in obesity-driven MASLD: Snitching on adipose-derived extracellular vesicles.Acta pharmaceutica Sinica. B
Letter: Interpreting Rule-Out and Rule-In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction-Associated Steatotic Liver Disease. Authors' Reply.Alimentary pharmacology & therapeutics
Serum Interferon Gamma-induced Protein 10 Levels in Patients with Type 2 Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease: A Case-control Study.Saudi journal of medicine & medical sciences
A bioactive ginsenoside alleviates hepatocellular ferroptosis induced by oxidized phospholipid accumulation in nonalcoholic steatohepatitis.iMeta
GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: A Review.Cardiology in review
Duodenal-Jejunal Bypass Stent Versus Laparoscopic Sleeve Gastrectomy in Patients With Obesity and MASLD: Short-Term Efficacy and Perioperative Safety in a Retrospective Cohort Study.Diabetes, obesity & metabolism
Early Changes in Peripancreatic Mesenteric Fat Beyond Weight Loss Predict Durability of Hepatic Improvements in MASLD.Diabetes, obesity & metabolism
Atractylenolide III alleviates MASLD by inhibiting lipid synthesis and apoptosis via PTEN.Phytomedicine : international journal of phytotherapy and phytopharmacology
Sleep Efficiency and Physical Capacity in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Cross-Sectional Study.Journal of sleep research
High Discrimination, Uncertain Triage: Interpreting Ultrasound-Based MASH Risk Classification.Journal of gastroenterology and hepatology
Therapeutic Signals Without Histologic Certainty: FGF Analogues in Compensated MASH Cirrhosis-A Systematic Review and Meta-Analysis.Diabetes, obesity & metabolism